ASCO 2019: The future of Keytruda plus chemo combination therapy
Checkpoint inhibitor combination strategies remains a focus of development, but chemo combos are not a slam dunk for every indication. As the 40,000... In DRG Blog/ June, 2019 Early-Stage NSCLC Development: More Than Consolidating
Immune checkpoint inhibitors continue to yield encouraging results among early-stage NSCLC patients at ASCO 2019 Impressive five-year survival data... In DRG Blog/ June, 2019 The Changing Specialty Drug Reimbursement Landscape
Advancements in medicine have led to the development of new specialty drugs treating a greater number of rare conditions. In the early 1990s,... In DRG Blog, Market Access/ June, 2019 Breast Cancer: A Model Indication for Personalized Medicine
The Heterogeneity of Breast Cancer Since its conception almost two decades ago, the strategy to base treatment selection on HR- and HER2-status has... In DRG Blog, Market Access/ June, 2019 ASCO 2019: Therapy Options in Bladder Cancer are Finally Diversifying
Emerging therapies with new mechanisms of action are offering more diverse therapeutic options for bladder cancer patients. Historically, for patients... In DRG Blog, Market Access/ June, 2019 EuroPCR 2019: 4 Hot Topics to Follow
This year’s EuroPCR conference was abuzz with lots of new innovations and market dynamics impacting the cardiovascular space. Our experts narrowed... In DRG Blog, Market Access, MedTech/ June, 2019 ASCO 2019: What's Noteworthy in the CAR T-Cells Corner?
CAR T-cell therapies continue their progress to change cancer treatment paradigms. CAR T Cells and solid tumors Targeting solid tumors with CAR T... In DRG Blog, Market Access, MedTech/ June, 2019 Will Primary Cares Court Medicare Shared Savings Program Participants?
The Centers for Medicare & Medicaid Services and Department of Health and Human Services have pursued shared-risk initiatives to move providers... In DRG Blog, Market Access, MedTech/ June, 2019 Growing Patient Involvement in Health Technology Assessment (HTA)
Health technology assessment (HTA) agencies such as National Institute for Health and Care Excellence (NICE - UK), Scottish Medicines Consortium (SMC... In DRG Blog, Market Access, MedTech/ May, 2019 Ophthalmology on a Roll: Key U.S. Market Events in May 2019
New product launches, product acquisitions, and life-cycle management strategies for existing products (e.g., expansion into related indication) are... In DRG Blog, Market Access, MedTech/ May, 2019 Will Consolidation in Chicago Force More Risk-Sharing in the Future?
Chicago health systems traditionally align with one of the city’s famous neighborhoods: University of Chicago Medicine in Hyde Park on the South... In DRG Blog, Market Access, MedTech/ May, 2019 Top Selling Drugs in CA Include Synthroid, Proair, Truvada, and Humira
Hormonal, respiratory tract, antiviral, and immunological agents are among the most frequently prescribed brand name and specialty drugs in California... In DRG Blog, Market Access, MedTech/ May, 2019 Pharma, Maryland Square Off Once Again Over Drug Pricing Controls
After suffering a bitter defeat to the pharmaceutical industry with the demise of their anti-price gouging law, Maryland lawmakers are attempting to... In DRG Blog, Market Access, MedTech/ May, 2019 In China 4+7 equals quality generic medicines at affordable costs
China is overhauling its healthcare system to align with the changing economic and demographic situation China’s healthcare system is undergoing a... In DRG Blog, Market Access, MedTech/ May, 2019 WHO Takes The Temperature of Global Physicians on Telehealth and Digital tools
Digital health tools hold exciting potential here in the wealthy world – to boost adherence, for example, or to facilitate a smoother patient... In DRG Blog, Market Access, MedTech, Digital Innovation/ May, 2019 What’s the Future of Medicaid Work Requirements After Court Ruling?
In a blow to the Trump administration’s goal for Medicaid recipients to “rise out of poverty and government dependence,” a federal judge blocked... In DRG Blog, Market Access, MedTech, Digital Innovation/ May, 2019 CMS Launches New Primary Care Payment Model. What’s Next?
The Centers for Medicare & Medicaid Services just announced Primary Cares, a group of initiatives set to begin in January 2020, with the goal of... In DRG Blog, Market Access, MedTech, Digital Innovation/ May, 2019 What Is the Current State Of BREXIT, And What Happens Next?
On March 29, 2017, the United Kingdom (UK) invoked Article 50 of the Lisbon Treaty, beginning the two-year process of leaving the European Union (EU... In DRG Blog, Market Access, MedTech, Digital Innovation/ April, 2019 Pharma’s next play: Pill-plus-Skill?
With last week’s headlines that Amazon has HIPAA-proofed Alexa, voice applications for health are back in the news. The first crop of HIPAA-... In DRG Blog, Market Access, MedTech, Digital Innovation/ April, 2019 Virginia and West Virginia Ban Copay Accumulators. What’s Next?
In March 2019, Virginia and West Virginia became the first states in the nation to ban copay accumulators—an increasingly common benefit adjustment... In DRG Blog, Market Access, MedTech, Digital Innovation/ April, 2019